PB2275: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB PLUS CHEMOTHERAPY VERSUS RITUXIMAB PLUS CHEMOTHERAPY IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA (OLYMPIA-2)

Detalles Bibliográficos
Autores principales: Novelli, Silvana, Risal, Ashish, Namuduri, Manjusha, Cai, Jingxian, Ufkin, Melanie, Zhu, Min, Mukherjee, Sushmita, Brouwer-Visser, Jurriaan, Chaudhry, Aafia, Mohamed, Hesham, Ambati, Srikanth, Iskierka-Jażdżewska, Elżbieta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429717/
http://dx.doi.org/10.1097/01.HS9.0000975832.38492.3b

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429717/
http://dx.doi.org/10.1097/01.HS9.0000975832.38492.3b

Ejemplares similares